Acrivon Therapeutics trades below cash value, with the market deeply discounting its platform and pipeline despite promising ...

The security vendor’s global CTO argues that AI’s non-deterministic nature requires a new approach to cybersecurity that ...

Many cancer-associated mutational signatures remain unexplained. Team CAUSE aims to connect DNA damage, mutational patterns, ...

New research shows it’s possible to edit the DNA of human embryos with more precision. But scientists warn it’s still not ...

MAIA recently announced that it has completed international enrollment in Part C of the Phase 2 THIO-101 expansion trial. Treatment with ateganosine followed by cemiplimab has shown an acceptable ...

There is one thing that is the leading cancer risk factor, responsible for 60 percent of all diagnoses - it outranks smoking, ...

A surprising new study found that young neurons naturally break and repair their DNA while migrating through the developing brain. This remarkable process appears to be essential for healthy brain ...